- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 6: Standardizing Clinical Pathways Across Health Plans
While providers would be relieved of their administrative burden, standardizing care pathways across health plans may not be an easy task, Blase Polite, MD, MPP, explains.
Surabhi Dangi-Garimella, PhD, asked what might be the administrative burdens for physicians as they try to adopt pathways that are not as standardized or different pathways prescribed by each health plan.
Blase Polite, MD, MPP, acknowledged that incorporating certain pathways into clinics can be a clunky process. He explained that a few of the US oncology practices have used pathways for 10-15 years, and this simplifies things as pathways can help make the choice of chemotherapy that is administered. For those practices that use pathways as a standalone, there have been some extra administrative burdens, and oncologists have been frustrated with the electronic health record.
As for adopting individual pathways for different providers, Dr Polite said that that situation would face considerable blowback from the oncology community; 1 single pathway would be simpler, and in order to unify, there would be need for consensus amongst payers, providers, and pharma. “[I]f it’s going to be some quasi-governmental deeming process like we do with clinical data registries you need to have buy-in from all the stakeholders.” explained Dr Polite. Without them, the process would be much more difficult.
Despite predicting some issues and disagreements, however, Dr Polite believes that consensus can be reached without great difficulty.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
